The much larger, headline-grabbing numbers associated with cagrilintide in the press figures in the low-to-mid 20% range come from Phase 3 trials of CagriSema , the combination with semaglutide, and are company-reported topline results, not standalone-cagrilintide data and not the peer-reviewed Phase 2 result cited above
Updates in diabetic peripheral neuropathy
In severe cases, dialysis or kidney transplantation may become necessary
95% CI, 0.05 to 0.52
Costabel U, Albera C, Lancaster LH, Lin CY, Hormel P, Hulter HN, Noble PW
These insights inform whether oral or injectable semaglutide, microdose protocols, or dual-compound options may align best with your genetic profilehelping optimize treatment choice and timing before you begin therapy